Variable | All patients* n=839 | No history of CVD* n=562 (67%) | History of CVD* n=277 (33%) | P value |
Composite outcome (death or MACE) | 225 (27) | 83 (15) | 142 (51) | <0.001 |
In-hospital death (all-cause) | 152 (18) | 51 (9) | 101 (36) | <0.001 |
MACE | 149 (18) | 43 (8) | 106 (38) | <0.001 |
Heart failure | 89 (11) | 18 (3) | 71 (26) | <0.001 |
Major arrhythmia | 45 (5) | 23 (4) | 22 (8) | 0.03 |
Non-fatal MI (STEMI, NSTEMI) | 16 (2) | 4 (1) | 12 (4) | <0.001 |
Non-fatal stroke | 10 (1) | 4 (1) | 6 (2) | 0.090 |
CV death | 55 (7) | 7 (1) | 48 (17) | <0.001 |
Myocarditis | 3 (0) | 2 (0) | 1 (0) | 1 |
Venous thrombotic complications † | 35 (4) | 25 (4) | 10 (4) | 0.70 |
Hospitalisation | ||||
Length of stay (days) | 10 (6–16) | 9 (5–14) | 12 (7–20) | <0.001 |
Rehabilitation | 142 (17) | 75 (13) | 67 (24) | <0.001 |
Length of stay (days) | 16 (10–24) | 16 (10–25) | 15 (10–23) | 0.70 |
ICU stay | 102 (12) | 73 (13) | 29 (10) | 0.35 |
Length of stay (days) | 12 (8–17) | 12 (8–17) | 12 (6–17) | 0.40 |
Invasive ventilation | 93 (91) | 68 (93) | 25 (86) | |
Duration (days) | 10 (7–15) | 10 (8–15) | 10 (7–12) | |
Dialysis | 7 (7) | 4 (5) | 3 (10) | |
ECMO | 11 (11) | 8 (11) | 3 (10) | |
IMCU stay | 135 (16) | 84 (15) | 51 (18) | 0.24 |
Length of stay (days) | 4 (2–6) | 3 (2–5) | 4 (2–6) | 0.43 |
Except for lengths of stay (Welch Student test), all p values are according to χ2 test or Fisher’s exact test.
*Data are n (%) or median (Q1–Q3).
†Venous thrombotic complications include: pulmonary embolism, portal vein thrombosis and deep vein thrombosis.
ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; IMCU, intermediate care unit; MACE, major adverse cardiovascular events.